2 not yet recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 2 |
Follow orforglipron: new trials by email Literature Review of orforglipron trials Research Report on orforglipron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation Phentermine Pill, Orforglipron - Obesity | Phase 4 | Not yet recruiting | Massachusetts General Hospital | 60 | 2026-11-01 | 2026-07-27 |
| PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses Orforglipron - Diabete Type 2, Pharmacogenomic Drug Interaction | Phase 4 | Not yet recruiting | Massachusetts General Hospital | 100 | 2026-10-01 | 2026-08-31 |
Diabetes Mellitus, Type 2 (1) · Obesity (1)
Massachusetts General Hospital (2)
United States (1)
R01DK148455 (1)